imatinib
网络释义：伊马替尼；格列卫；依马替尼
网络释义
1.伊马替尼 ... Ifosfamide 异环磷酰胺 3778-73-2 Imatinib 依马替尼 220127-57-1 Irinotecan 伊立替康 136572-09-…
4.伊玛替尼 ... 和C-反应蛋白( C- reactive protein，CRP) 使对伊马替尼( imatinib， 2. 埃罗替尼( Tarceva，erlotinib) ...
6.替尼布近年，医学研究出一种名为依麦替尼布（Imatinib） 的药物，能特别有效针对基质肿瘤，可减低手术后的复发机会或在扩散的情 …
7.伊马替你# 伊马替你（Imatinib）：BCR-ABl酪氨酸激酶抑制剂，是一线治疗药物。68%的病人达到遗传性缓解# 羟基脲±白血病分离用于 …
8.伊妈替尼酪氨酸激酶抑制剂如血小板衍生生长因子（PDGF）受体拮抗剂伊妈替尼（Imatinib）或者多激酶抑制剂索拉非尼（orafenib）已 …
例句释义:,伊马替尼,格列卫,依马替尼1.When they tried Gleevec, known generically as imatinib, it had pttle effect on the cells.当他们尝试着格列卫，通常被称依马替尼，它很少对细胞有作用。
2.Background Nilotinib has been shown to be a more potent inhibitor of BCR-ABL than imatinib.有研究表明与伊马替尼相比，尼罗替尼是一种更强效的BCR-ABL抑制剂。
3.Consider using adjuvant imatinib for at least 3 (rather than 1) years in high-risk patients after resection of GIST.考虑对手术切除后的GIST高危患者应用辅助伊马替尼治疗至少3年（而不是1年）。
4.Imatinib mesylate pharmacokinetics before and after sleeve gastrectomy in a morbidly obese patient with chronic myeloid leukemia.之前和之后在慢性粒细胞白血病病态肥胖病人的胃切除甲磺酸伊马替袖子药代动力学。
5.Drugs pke imatinib and sunitinib inhibit their primary target in a nanomolar concentration.如imatinib和sunitinib这样的药物在纳摩尔浓度就抑制它们的主要靶点。
6.Objective To explore the inhibitory mechanism of Imatinib mesylate on pulmonary fibrosis induced by bleomycin in mice.目的探讨格列卫对小鼠肺纤维化的干预机制。
7.The next step, says Jiang is finding a drug that blocks AHI-1, which could potentially be given in combination with imatinib in the future.江表示，下一步是找一种阻滞AHI-1的药物，这种药物可能在将来与伊马替尼联用于治疗。
8.Imatinib is currently the most popular therapy for chronic myeloid leukemia (CML).伊马替尼是目前治疗慢性髓细胞白血病的最普遍药物。
9.Imatinib was re introduced in patients who had molecular relapse.出现分子学复发的患者，再次应用伊马替尼。
10.But imatinib is known to cause heart problems in some people because it also switches off tyrosine kinases in the ABL family.但伊马替尼是众所周知的导致心脏问题，在一些人，因为它还要开关小康酪氨酸激酶在abl的家庭。